The Library

Is sunlight good for our heart?

Tools

Feelisch, Martin, Kolb-Bachofen, Victoria, Liu, Donald, Lundberg, Jon O., Revelo, Lucia P., Suschek, Christoph V. and Weller, Richard B.. (2010) Is sunlight good for our heart? European Heart Journal , Vol.31 (No.9). pp. 1041-1045. ISSN 1522-9645

PDF
WRAP_Feelisch_EURHEARTJ-D-09-02860-revision_final.pdf - Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader
Download (403Kb)

Official URL: http://dx.doi.org/10.1093/eurheartj/ehq069

Abstract

Humans evolved being exposed for about half of the day to the light of the sun. Nowadays, exposure to sunlight is actively discouraged for fear of skin cancer, and contemporary lifestyles are associated with long hours spent under artificial light indoors. Besides an increasing appreciation for the adverse effects of these life-style-related behavioural changes on our chronobiology, the balance between the beneficial and harmful effects of sunlight on human health is the subject of considerable debate, in both the scientific and popular press, and the latter is of major public health significance. While there is incontrovertible evidence that ultraviolet radiation (UVR) in the form of sunlight is a significant predisposing factor for non-melanoma and melanoma skin cancers in pale skinned people,1 a growing body of data suggest general health benefits brought about by sunlight.2 These are believed to be mediated either by melatonin or vitamin D. Melatonin is produced from serotonin by the pineal gland located in the centre of the brain during periods of darkness, and its release is suppressed as a function of the visible light intensity sensed through ocular photoreceptors. Vitamin D is formed by ultraviolet B (UVB)-mediated photolysis of 7-dehydrocholesterol in the skin. Both melatonin and vitamin D are pleiotropic hormones that exert a multitude of cellular effects by interacting with membrane and nuclear receptors, and receptor-independent actions. People with more heavily pigmented skin require higher doses of UVB to produce adequate amounts of vitamin D, and this may have been an evolutionary driver to the variation of human skin colour with latitude and intensity of solar irradiation. Our degree of exposure to sunlight is easily modified by behavioural factors such as the use of clothing, sunglasses, and sun-blocking creams, and time spent outdoors. Balancing the carcinogenic risks with the requirement for vitamin D has led to advice on moderating sun exposure, while supplementing food with vitamin D. Guidance on such behaviour is part of the public health campaigns in most countries with Caucasian populations. Following these suggestions, we may, however, be missing out on other health benefits provided by natural sunlight that are less obvious and unrelated to the above classical mediators.

Item Type:

Journal Article

Subjects:

Q Science > QP Physiology

Divisions:

Faculty of Medicine > Warwick Medical School > Translational & Systems Medicine > Metabolic and Vascular Health
Faculty of Medicine > Warwick Medical School

Library of Congress Subject Headings (LCSH):

Sunshine -- Health aspects, Cardiovascular system -- Diseases -- Prevention, Ultraviolet radiation -- Physiological effect , Nitric oxide

Journal or Publication Title:

European Heart Journal

Publisher:

Oxford University Press

ISSN:

1522-9645

Official Date:

May 2010

Dates:

Date	Event
May 2010	Published

Volume:

Vol.31

Number:

No.9

Page Range:

pp. 1041-1045

Identification Number:

10.1093/eurheartj/ehq069

Status:

Peer Reviewed

Publication Status:

Published

Access rights to Published version:

Restricted or Subscription Access

References:

1. Rigel DS. Cutaneous ultraviolet exposure and its relationship to the development of skin cancer. J Am Acad Dermatol 2008;58(5 Suppl 2):S129-S132.
2. Moan J, Porojnicu AC, Dahlback A, Setlow RB. Addressing the health benefits and risks, involving vitamin D or skin cancer, of increased sun exposure. Proc Natl Acad Sci U S A 2008;105(2):668-673.
3. Brennan PJ, Greenberg G, Miall WE, Thompson SG. Seasonal variation in arterial blood pressure. Br Med J (Clin Res Ed) 1982;285(6346):919-923.
4. Rostand SG. Ultraviolet light may contribute to geographic and racial blood pressure differences. Hypertension 1997;30(2 Pt 1):150-156.
5. Law MR, Morris JK. Why is mortality higher in poorer areas and in more northern areas of England and Wales? J Epidemiol Community Health 1998;52(6):344-352.
6. Wannamethee SG, Shaper AG, Whincup PH, Walker M. Migration within Great Britain and cardiovascular disease: early life and adult environmental factors. Int J Epidemiol 2002;31(5):1054-1060.
7. Kloner RA, Poole WK, Perritt RL. When throughout the year is coronary death most likely to occur? A 12-year population-based analysis of more than 220 000 cases. Circulation 1999;100(15):1630-1634.
8. Douglas AS, al Sayer H, Rawles JM, Allan TM. Seasonality of disease in Kuwait. Lancet 1991;337(8754):1393-1397.
9. Oplander C, Volkmar CM, Paunel-Gorgulu A, van Faassen EE, Heiss C, Kelm M, Halmer D, Murtz M, Pallua N, Suschek CV. Whole Body UVA Irradiation Lowers Systemic Blood Pressure by Release of Nitric Oxide From Intracutaneous Photolabile Nitric Oxide Derivates. Circ Res 2009.
10. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002;360(9349):1903-1913.
11. Leal J, Luengo-Fernandez R, Gray A, Petersen S, Rayner M. Economic burden of cardiovascular diseases in the enlarged European Union. Eur Heart J 2006;27(13):1610-1619.
12. Devol R, Bedroussian A. An Unhealthy America: The Economic Burden of Chronic Disease -- Charting a New Course to Save Lives and Increase Productivity and Economic Growth. Milken Institute; 2007.
13. Palmer RM, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987;327(6122):524-526.
14. Rassaf T, Preik M, Kleinbongard P, Lauer T, Heiss C, Strauer BE, Feelisch M, Kelm M. Evidence for in vivo transport of bioactive nitric oxide in human plasma. J Clin Invest 2002;109(9):1241-1248.
15. Lundberg JO, Weitzberg E, Gladwin MT. The nitrate-nitrite-nitric oxide pathway in physiology and therapeutics. Nat Rev Drug Discov 2008;7(2):156-167.
16. Butler AR, Feelisch M. Therapeutic uses of inorganic nitrite and nitrate: from the past to the future. Circulation 2008;117(16):2151-2159.
17. Matsunaga K, Furchgott RF. Interactions of light and sodium nitrite in producing relaxation of rabbit aorta. J Pharmacol Exp Ther 1989;248(2):687-695.
18. Rodriguez J, Maloney RE, Rassaf T, Bryan NS, Feelisch M. Chemical nature of nitric oxide storage forms in rat vascular tissue. Proc Natl Acad Sci U S A 2003;100(1):336-341.
19. Paunel AN, Dejam A, Thelen S, Kirsch M, Horstjann M, Gharini P, Murtz M, Kelm M, de Groot H, Kolb-Bachofen V, Suschek CV. Enzyme-independent nitric oxide formation during UVA challenge of human skin: characterization, molecular sources, and mechanisms. Free Radic Biol Med 2005;38(5):606-615.
20. Bruch-Gerharz D, Ruzicka T, Kolb-Bachofen V. Nitric oxide in human skin: current status and future prospects. J Invest Dermatol 1998;110(1):1-7.
21. Weller R, Pattullo S, Smith L, Golden M, Ormerod A, Benjamin N. Nitric oxide is generated on the skin surface by reduction of sweat nitrate. J Invest Dermatol 1996;107(3):327-331.
22. Whitlock DR, Feelisch M. Soil Bacteria, Nitrite, and the Skin. In: Rook GAW, ed. The Hygiene Hypothesis and Darwinian Medicine.Basel: Birkhaeuser Publishing; 2009. p. 103-115.
23. Mowbray M, McLintock S, Weerakoon R, Lomatschinsky N, Jones S, Rossi AG, Weller RB. Enzyme-independent NO stores in human skin: quantification and influence of UV radiation. J Invest Dermatol 2009;129(4):834-842.
24. Bryan NS, Fernandez BO, Bauer SM, Garcia-Saura MF, Milsom AB, Rassaf T, Maloney RE, Bharti A, Rodriguez J, Feelisch M. Nitrite is a signaling molecule and regulator of gene expression in mammalian tissues. Nat Chem Biol 2005;1(5):290-297.
25. Duranski MR, Greer JJ, Dejam A, Jaganmohan S, Hogg N, Langston W, Patel RP, Yet SF, Wang X, Kevil CG, Gladwin MT, Lefer DJ. Cytoprotective effects of nitrite during in vivo ischemia-reperfusion of the heart and liver. J Clin Invest 2005;115(5):1232-1240.
26. Lundberg JO, Govoni M. Inorganic nitrate is a possible source for systemic generation of nitric oxide. Free Radic Biol Med 2004;37(3):395-400.
27. Larsen FJ, Ekblom B, Sahlin K, Lundberg JO, Weitzberg E. Effects of dietary nitrate on blood pressure in healthy volunteers. N Engl J Med 2006;355(26):2792-2793.
28. Webb AJ, Patel N, Loukogeorgakis S, Okorie M, Aboud Z, Misra S, Rashid R, Miall P, Deanfield J, Benjamin N, MacAllister R, Hobbs AJ, Ahluwalia A. Acute blood pressure lowering, vasoprotective, and antiplatelet properties of dietary nitrate via bioconversion to nitrite. Hypertension 2008;51(3):784-790.
29. Jansson EA, Huang L, Malkey R, Govoni M, Nihlen C, Olsson A, Stensdotter M, Petersson J, Holm L, Weitzberg E, Lundberg JO. A mammalian functional nitrate reductase that regulates nitrite and nitric oxide homeostasis. Nat Chem Biol 2008;4(7):411-417.
30. Dejam A, Kleinbongard P, Rassaf T, Hamada S, Gharini P, Rodriguez J, Feelisch M, Kelm M. Thiols enhance NO formation from nitrate photolysis. Free Radic Biol Med 2003;35(12):1551-1559.
31. McLaren M, Kirk G, Bolton-Smith C, Belch JJ. Seasonal variation in plasma levels of endothelin-1 and nitric oxide. Int Angiol 2000;19(4):351-353.
32. Ringqvist A, Leppert J, Myrdal U, Ahlner J, Ringqvist I, Wennmalm A. Plasma nitric oxide metabolite in women with primary Raynaud's phenomenon and in healthy subjects. Clin Physiol 1997;17(3):269-277.
33. Perlman DH, Bauer SM, Ashrafian H, Bryan NS, Garcia-Saura MF, Lim CC, Fernandez BO, Infusini G, McComb ME, Costello CE, Feelisch M. Mechanistic insights into nitrite-induced cardioprotection using an integrated metabolomic/proteomic approach. Circ Res 2009;104(6):796-804.
34. Dezfulian C, Shiva S, Alekseyenko A, Pendyal A, Beiser DG, Munasinghe JP, Anderson SA, Chesley CF, Vanden Hoek TL, Gladwin MT. Nitrite therapy after cardiac arrest reduces reactive oxygen species generation, improves cardiac and neurological function, and enhances survival via reversible inhibition of mitochondrial complex I. Circulation 2009;120(10):897-905.
35. Garcia-Saura MF, Fernandez BO, McAllister BP, Whitlock DR, Cruikshank WW, Feelisch M. Dermal Nitrite Application Enhances Global Nitric Oxide Availability: New Therapeutic Potential for Immunomodulation? J Invest Dermatol 2009 Oct 8. [Epub ahead of print].
36. Lohr NL, Keszler A, Pratt P, Bienengraber M, Warltier DC, Hogg N. Enhancement of nitric oxide release from nitrosyl hemoglobin and nitrosyl myoglobin by red/near infrared radiation: potential role in cardioprotection. J Mol Cell Cardiol 2009;47(2):256-263.